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Abstract 
Background: Abdominal obesity (AO) is a common modifiable risk factor for certain non‑communicable diseases 
associated with enhanced oxidative stress (OS). The objective of this work was to investigate whether the interaction 
between antioxidant vitamin intake and OS‑related polymorphisms modulates gene‑associated anthropometry in a 
Spanish population.
Methods: A total of 246 subjects with AO, and 492 age and gender matched non‑AO subjects were included in the 
study. Anthropometric, biochemical, and OS parameters, and antioxidant dietary intake data were assessed using vali‑
dated procedures. DNA from white blood cells was isolated and the genotype of seven polymorphisms from genes 
involved in OS (pro‑oxidant and antioxidant) were analyzed using the SNPlex system. The effects of the c.‑793T > C 
polymorphism on promoter activity and thus thioredoxin (TXN) activity were examined using reporter assays.
Results: The AO group had higher 8‑Oxo‑2′‑deoxyguanosine levels and took in less vitamin A and vitamin E com‑
pared to the non‑AO group. Logistic regression analysis revealed that the rs2301241 polymorphism in TXN and 
rs740603 in catechol‑O‑methyltransferase (COMT) were associated with waist circumference (WC) and AO. Moreover, 
these polymorphisms were more strongly associated with variations in WC in subjects with low vitamin E intakes. A 
promoter assay revealed that the T to C conversion at c.‑793 (rs2301241) induced a more than two fold increase in 
reporter gene expression.
Conclusions: WC is associated both with dietary vitamin E intake and genetic variants of TXN and COMT suggesting 
that existence of a complex nutrigenetic pathway that involves regulation of AO.
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Background
The increasing number of overweight and obese peo-
ple (with a body mass index (BMI) of 25 or more) is a 
well-recognized public health problem in Europe and 
in other developed countries [1]; in Spain this group 
accounts for an estimated 60  % of the population, 
although the prevalence varies among European regions 
[2, 3]. Moreover, the prevalence of abdominal obesity 
(AO), as estimated independently of BMI by using waist 
circumference (WC) as a proxy, varied between 3.8 and 
33.2  % in the studied countries, and is about 20  % in 
Spain [4]. AO is known to increase the risk of particular 
Open Access
*Correspondence:  m.luisa.mansego@uv.es 
†Maria L. Mansego and Griselda de Marco contributed equally to this 
work
2 Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del 
Hospital Clínico de Valencia‑INCLIVA, Av. Blasco Ibañez 17, 46010 Valencia, 
Spain
Full list of author information is available at the end of the article
Page 2 of 11Mansego et al. J Transl Med  (2015) 13:286 
diseases, particularly type 2 diabetes, resulting in a 
greater risk of death [5, 6].
Factors related to the development of visceral adiposity 
are complex and multiple mechanisms have been impli-
cated [7], although one of these mechanisms, increased 
oxidative stress (OS), is now being more intensively stud-
ied [8, 9]. The impact of increased quantities of reac-
tive oxygen species (ROS) on several cellular systems in 
patients with AO has recently been described as a con-
tributing factor not only to systemic OS but also to the 
overall fat storage pattern [10]. In fact, ROS in adipocyte 
cells produce alterations in the endoplasmic reticulum 
which increases the proportion of unfolded or misfolded 
proteins and thus also cellular stress [11]. Furthermore, 
they allow long-chain fatty acids bound to coenzyme A 
to accumulate, which lowers mitochondrial activity and 
encourages fat storage. Likewise, OS increases insulin 
resistance which further contributes to fat accumulation 
in muscle, liver, and adipose tissue [12].
The level of OS depends on the interplay of both enzy-
matic and non-enzymatic pro-oxidant and antioxidant 
mechanisms, and dietary antioxidant intake seems to 
have an important role. Hence, low intake levels of the 
main antioxidant vitamins (vitamins A, C, and E) have 
been associated with undesirable anthropometric param-
eters such as increased BMI and waist perimeter. In addi-
tion, antioxidant diets can modulate the generation of 
both ROS and antioxidant molecules, which are partly 
controlled by genes coding for proteins in different sys-
tems [13, 14]. Vitamin E has been described to moder-
ately improve OS status and glucose metabolism in an 
animal model of diet-induced obesity [15] and chronic 
dietary vitamin A supplementation regulates obesity 
in obese-phenotype rats, possibly by upregulating the 
uncoupling protein 1 (UCP1) gene thus causing adipose 
tissue loss [16].
Certain single-nucleotide polymorphisms (SNPs) in 
antioxidant enzymes (including superoxide dismutase 
(SOD), glutathione peroxidase (GPX), catalase (CAT), 
or thioredoxin (TXN)) or in oxidant enzymes (such as 
catechol-O-methyltransferase (COMT)) may lead to 
decreased or impaired enzymatic activity regulation 
thereby promoting OS [17]. There is also evidence that 
diet can interact with genetic variation, causing inflamma-
tion and dyslipidemia [18, 19]. Interestingly, CAT alleles 
with the T-20C (rs1049982) SNP are associated with 
improved recovery from malnutrition in elderly patients, 
therefore suggesting that high-risk subpopulations could 
be identified by genotyping [20]. However, there is scarce 
information available regarding the effect of antioxidant 
intake and the influence of OS-related gene polymor-
phisms on anthropometric parameters. Therefore, the 
aim of the present study was to investigate whether the 
interaction between antioxidant vitamin (vitamins A, C, 
and E) intake and OS-related polymorphisms modulates 
gene-associated anthropometry in a Spanish population.
Methods
Subjects
We performed a case-controlled trial on a selected 
subsample of age and sex matched AO and non-AO 
individuals (1:2 ratio) from the Hortega study, a popu-
lation-based study in Valladolid, Spain [21]. All the sub-
jects included in the study were Caucasian and lived in 
an area with a low immigration rate. Four hundred and 
ninety-two control subjects were selected and compared 
to 246 subjects with AO according to the ATP-III criteria 
[22] (defined as an estimated WC of more than 102 cm in 
men or 88 cm or more in women). Inclusion criteria were: 
Caucasians older than 18 years old with no serious con-
comitant disease (epilepsy, psychosis, alcoholism, lung 
cancer, chronic cardiopulmonary heart disease, pulmo-
nary emphysema, or terminal disease with a life expec-
tancy of less than three months) or psychiatric disorders 
which could interfere with the study. All the procedures 
followed were in accordance with the 1975 Helsinki Dec-
laration, as revised in 2000 [23], and the standards of the 
local ethical committee for human experimentation (at 
the Clinic Hospital in Valencia, Spain, signed off on 28 
April 2011). Informed written consent was given by all 
patients included in the study.
Demographic characteristics, anthropometry, 
and biochemical assessments
Demographic characteristics included the age, sex, and 
education level of the subjects. The latter was grouped 
into two categories for analysis: less than high school or 
greater than or equal to high school. BMI was calculated 
as the ratio between weight (kg) and squared height (m2). 
Weight was measured using precise scales (without shoes 
and with patients wearing only light clothing) and height 
was determined in a similar way. WC was measured at 
the mid-level between the lower rib margin and the iliac 
crest, and hip circumference was measured at the point 
of maximum buttock extension; the waist-hip ratio 
(WHR) was calculated as WC divided by hip circumfer-
ence. All measurements were recorded by trained investi-
gators or nursing personnel. The inter-observer error rate 
was less than 2 cm.
After a mean of 3  h fasting, venous blood samples 
were collected into k3-EDTA tubes for hematological 
and biochemical profiling using extracted nucleated-cell 
DNA. Basic serum biochemistry and lipid profiles (total 
cholesterol, high-density lipoprotein [HDL] cholesterol, 
and triglycerides) were assessed with a Hitachi 917 auto-
analyzer (Boehringer, Germany). Glucose was measured 
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using the glucose-oxidase method and low-density 
lipoprotein (LDL) cholesterol was calculated using the 
Friedewald formula. Metabolic syndrome was defined by 
ATPIII criteria [24].
Oxidative stress parameters
Oxidative stress markers were measured in blood plasma. 
DNA damage, assessed by the formation of 8-oxo-deox-
yguanosine (8-OXO-DG) was quantified by high-perfor-
mance liquid chromatography (HPLC) electrochemical 
(EC) detection after complete enzymatic digestion [25]. 
Malondialdehyde (MDA), an indicator of o-lipid oxi-
dation, was analyzed by HPLC [26]. Protein content 
was measured using the Bradford method [27]. The 
glutathione system is the most important free-radical 
scavenger, therefore we measured the ratio of oxidized 
glutathione (GSSG) and reduced glutathione (GSH) as an 
estimation of the overall level of OS; GSSG was analyzed 
by HPLC and GSH was analyzed using the glutathione-S-
transferase assay [28].
Nutritional intake assessment
The Mediterranean diet is the typical diet for the geo-
graphical location of the population examined in this 
study. This typically includes proportionally high con-
sumption of olive oil, legumes, unrefined cereals, fruits, 
and vegetables, moderate to high consumption of fish, 
moderate consumption of dairy products (mostly as 
cheese and yogurt) and wine, and low consumption meat 
and meat products [29]. In this study 24  h recall food-
intake data were recorded on three different days (once 
during the interview, and then 4 and 8 weeks later, which 
were sent by the patient by mail). Experienced dietitians 
carried out the interview using the previously validated 
semi-quantitative Food Frequency Questionnaire (FFQ) 
to determine the number of portions of each food type 
consumed monthly; photographs were also used to deter-
minate portion sizes. These two independent methods of 
diet evaluation were averaged and the data was further 
analyzed as described below.
The dietary nutrient composition was determined at 
the Institute of Nutrition and Food Technology at the 
University of Granada using food composition tables and 
was analyzed with the previously-validated [30] Aliment-
ación y Salud (Food and Health) software program, ver-
sion 0689.01 (BitASDE General Médica Farmacéutica, 
Valencia, Spain) designed by the same institute. Vitamin 
A intake (in µg/day) and vitamin E and vitamin C intake 
(in mg/day) were estimated and all the participants were 
assigned into one of two groups based on their median 
vitamin E intake: “low’’ (9.0  mg/day or less) and ‘‘high’’ 
(more than 9.0 mg/day).
DNA isolation and single‑nucleotide polymorphism 
selection and genotyping
DNA was isolated from peripheral blood cells using the 
Chemagic system (Chemagen); its quality was assessed 
using the PicoGreen dsDNA Quantitation Reagent (Inv-
itrogen, Carlsbad, CA) and it was diluted to a final con-
centration of 100  ng/μl. Seven oxidative-stress related 
SNPs from six genes were selected based on their minor 
allele frequency (MAF) in Caucasians (0.1 or more), 
location, distribution, tag-SNP characteristics using the 
SySNP program (http://www.sysnps.org/‎), and their pos-
sible effects on function as determined in previous stud-
ies by our group [31]. The selected genes and reference 
names, chromosome position, locus, and the MAF of the 
selected SNPs are shown in Table  1. The selected SNPs 
were genotyped using a genotyping system based on an 
oligo-ligation assay/polymerase chain reaction technol-
ogy (SNPlex, Applied Biosystems, Foster City) following 
the manufacturer’s guidelines. The nomenclature of the 
polymorphisms is based on recommendations by den 
Dunnen and Antonaraki [32].
Measuring thioredoxin promoter activity
To construct a wild-type TXN reporter plasmid a 969-
bp fragment of the human TXN promoter (nucleotides 
−952 to +17 relative to the translation initiation site) 
was amplified with the following primers: (forward) 
5-CGGGGTACCATCAGTCCCTGCAAGACACC-3 
and (reverse) 5-GGAAGATCTTCGATCTGCTTCAC 
CATCTTGGC-3 from homozygote DNA samples with 
the rs2301241 (c.-793T  >  C) polymorphism. Reporter 
vectors containing the c.-793T  >  C variation were pro-
duced by oligonucleotide-based mutagenesis of the wild-
type reporter plasmid. PCR products (wild type and 
variant) were cloned into KpnI/BglII sites on the pGL3 
basic vector (Promega). The sequence and integrity of 
each construct were confirmed by dideoxynucleotide-
based sequencing.
Promoter assays were carried out by first growing 
HuH-7 cells in Dulbecco’s Modified Eagle’s medium 
containing 25  mM glucose, supplemented with 10  % 
fetal bovine serum and antibiotics (100 U/ml penicillin 
and 100  µg/ml streptomycin) at 37º C in a humidified 
atmosphere with 5  % CO2. Plasmid transfections were 
performed on attached cells at 50  % confluence. Cells 
were transfected using FuGENE®HD Transfection Rea-
gent (Roche Applied Science) with 1  mg of pGL3-TXN 
reporter constructs (wild type or mutated) and 50 ng of a 
promoter less renilla luciferase construct (pRL-0). Trans-
activation activity was measured 24  h after transfection 
in a Wallac 1420 VICTOR2 luminometer using the dual 
luciferase reporter assay system (Promega) following the 
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manufacturer’s instructions. Relative light units were 
determined by quantifying the signal from firefly lucif-
erase after normalizing it against co-transfected renilla 
luciferase activity in the same sample. Finally, these rela-
tive values were normalized against a mock transfection 
experiment. Each expression construct was transfected in 
triplicate wells and the experiments were repeated three 
times.
Measurement of plasma thioredoxin levels
The plasma level of TXN was measured using an enzyme-
linked immunosorbent assay kit following the manu-
facturer’s instructions (Cusabio Biotech Co., Ltd) in 88 
subjects with the rs2301241 SNP homozygote genotype 
(TT or CC). Samples were placed into micro-wells pre-
coated with a human-specific antibody (HRP-conjugate) 
and successively with one substrate and a chromogenic 
system. The reaction was stopped and the absorbance 
was read at 450 nm.
Statistical analysis
Data are expressed as the mean (±the standard deviation, 
SD) except when otherwise indicated. The Hardy–Wein-
berg equilibrium was tested using the Chi square (χ2) 
test for each polymorphism. The participant character-
istics were assessed as a function of AO. The differences 
between the mean and SD for each variable were assessed 
by one-way analysis of variance (ANOVA), and were 
compared with contingency tables and using the χ2 test. 
The association between polymorphisms and anthropo-
metric parameters (BMI, WC, and hip and WHR) and OS 
were examined using analysis of covariance (ANCOVA), 
focusing on the dominant model. The association of AO 
with each polymorphism was analyzed by logistic regres-
sion, adjusting the model for the confounding variables 
of age, gender, education level, hypertension, glucose, 
HDL-cholesterol, triglycerides, 8-OXO-DG, and alcohol 
consumption, except as otherwise indicated.
To identify gene–gene interactions we implemented a 
genetic, model-free, non-parametric multifactor dimen-
sionality reduction (MDR) strategy [33] using 100-fold 
cross validation and 1000-fold permutation testing. We 
used the MDR software (version 3.0.2) which is freely 
available (http://www.epistasis.org). MDR results were 
considered statistically significant at the p = 0.05 level. We 
used ANOVA to study the interaction between diet, vita-
mins A and E, the WC-associated SNPs (rs2301241 for the 
TXN genotype or rs740603 for the COMT genotype), and 
WC, using the same covariate factors mentioned above.
Pearson correlations were fitted to evaluate any poten-
tial correlation between OS parameters and anthropo-
metric measurements, metabolic features, and dietary 
factors. Statistical analyses were performed with SPSS 
19.0 software (SPSS Inc., Chicago, IL, USA). A P value 
of less than 0.05 was considered to be statistically signifi-
cant, except for the genotype association analysis where 
we used the Bonferroni correction: 0.05/(number of 
SNPs; 7) giving statistical significance at p value <0.007.
Results
General study population characteristics
A total of 738 participants, 390 (52.8 %) men, were suitable 
for the analysis. The main study population characteristics, 
grouped by AO, are presented in Table 2. A total of 246 AO 
and 492 non-AO individuals were included. As expected, 
participants allocated to the AO group had a higher BMI, 
WC, and hip and WHR than the non-AO group. There 
were also significant differences in the levels of glucose, tri-
glycerides, hypertension, metabolic syndrome, and alcohol 
consumption between AO-classification groups; in addi-
tion, HDL-cholesterol was generally higher and education 
levels poorer in the AO group.
Table 1 Characteristics of selected polymorphisms
HGN HUGO gene nomenclature, Chr chromosome
a NCBI dbSNP Build 126
b Tag-SNP by HapMap in Caucasoid subjects (Y yes)
c Begins in the first nucleotide 5′ of the ATG start codon, Build 126, Ensembl release 41 as suggested by the Human Gene Nomenclature Committee (HGNC)
d MAF (minor allele frequency), data obtained from 1000 genomes
HGN Gene name dbSNPa Tag‑SNPb Chr position Referencec MAFd
CAT Catalase rs1049982 Y 11:34417117 c.‑20C > T 0.36
SOD3 Superoxidedismutase 3 rs2536512 Y 4:24410413 c.172G > A (p.A58T) 0.37
GPX1 Glutathione peroxidase 1 rs3448 Y 3:49371755 c.*891C > T 0.25
TXN Thioredoxin rs4135168 Y 9:112056706 c.24 + 1807G > A 0.12
rs2301241 Y 9:112059329 c.‑793T > C 0.48
XDH Xanthine dehydrogenase rs17323225 2:31446769 c.1936T > C (p.I646V) 0.06
COMT Catechol‑O‑methyltransferase rs740603 Y 22:19945177 c.‑91‑3545G > A 0.39
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Oxidative stress and antioxidant dietary intake
OS parameter concentrations (8-OXO-DG, MDA, and 
the GSSG/GSH ratio) and dietary antioxidant (vita-
mins A, C, and E) intake, categorized by the presence or 
absence of AO are shown in Table  2. 8-OXO-DG levels 
were higher and vitamin A and E intake was significantly 
lower in AO patients than in non-AO participants.
Single‑nucleotide polymorphisms, oxidative stress 
parameters, anthropometry and abdominal obesity
The Hardy–Weinberg equilibrium was maintained for all 
SNPs in the study population except for rs17323225 that 
was excluded from subsequent analysis. No significant 
differences were observed for OS parameters accord-
ing to the selected SNP genotypes (data not shown). The 
TXN rs2301241 and the COMT rs740603 polymorphisms 
were significantly associated with WC after Bonfer-
roni correction (p  <  0.007; Table  3), and likewise, these 
two SNPs were associated with AO [TT vs. TC+CC 
rs2301241 genotypes, odds ratio [OR] = 0.70 [95 % con-
fidence interval (CI) 0.50–0.97, p  =  0.034] and GG vs. 
GA + AA genotypes for the rs740603 COMT polymor-
phism, OR = 0.73 (95 % CI 0.53–0.99, p = 0.045)]. There 
were no significant differences between the genders 
(Additional file 1: Table S1). To rule out the influence of 
other comorbidities associated with AO, we analyzed 
these two SNPs in patients with or without metabolic 
syndrome, but did not observe any significant association 
(Additional file  1: Table S2). Moreover, we categorized 
metabolic syndrome-related characteristics in the study 
population by the TXN and COMT SNP genotype, but 
found that only age differentially-associated depending 
on the genotype of each SNP (Additional file 1: Table S3). 
Statistical correlation analysis between biochemical and 
anthropometric parameters in AO and non-AO groups 
and according to these genotypes (Additional file 1: Table 
S4) showed that WC is only positively correlated with 
glucose in TT and GG carriers of TXN and COMT genes, 
respectively, in the non-AO group.
Figure  1 summarizes the best interaction models we 
obtained from the MDR analysis. The best two-locus 
model for predicting AO was rs2301241 (TXN) and 
rs740603 (COMT) with an improved testing-accuracy of 
57  % (cross-validation consistency, 100; permutation p 
value < 0.001). After identifying the high-risk allele com-
binations by MDR analysis, we applied a logistic regres-
sion to calculate the their possible effects, observing that 
the combination of the rs2301241 and rs740603 A and C 
alleles respectively, was associated with lower WCs [AC 
vs. TG allele combination, difference = −2.52 (95  % CI 
−3.89 to −1.15, p = 0.00033)] and AO [OR = 0.64 (95 % 
CI 0.46–0.89, p = 0.0087)].
Interaction between waist circumference, vitamin E intake, 
and single‑nucleotide polymorphisms
With regard to rs2301241 (TXN), the TT-genotype sub-
jects that consumed diets low in vitamin E had higher 
WCs than the C-allele carriers (Fig.  2a); the mean 
differences between these two genotypes were sig-
nificantly different in this group (3.16  cm; p  =  0.002, 
using a dominant [TC or CC] model). On the other 
hand, no significant genotype-based differences were 
found among subjects who consumed diets high in 
vitamin E. Carriers of the rs740603 (COMT) A allele 
who consumed diets low in vitamin E had a lower WC 
than homozygotes for the G allele (92.0  ±  12.1 vs. 
95.12 ± 13.14 cm, p = 0.002; Fig. 2b), whereas WC was 
higher in GG genotype carriers who consumed diets 
Table 2 General characteristics of  the study population, 
categorized by abdominal obesity
Data are mean (±SD). Education level was grouped into two categories for 
the analysis as less than high school (<high school) and greater than or equal 
high school. The value of 8-OXO-DG was expressed as the number of oxidized 
bases/106  deoxyguanosine. P values denote differences between non-AO 
group and AO group
Non-AO non-abdominal obesity group, AO abdominal obesity group, BMI body 
mass index, WC waist circumference, WHR waist hip ratio, SBP systolic blood 
pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, 8-OXO-DG 
8-oxo-deoxyguanosine, MDA malondialdehyde, GSH/GSSG ratio between 
reduced and oxidized glutathione
Variables Non‑AO (n = 492) AO (n = 246) p value
Age (years) 61 (17) 61 (17) 0.972
Gender (M/F) 260/232 130/116 1.000
Education level (<high 
school (%))
291 (59 %) 164 (67 %) 0.045
BMI (kg/m2) 26 (3) 30 (3) <0.001
WC (cm) 87 (10) 103 (9) <0.001
Hip (cm) 101 (6) 109 (8) <0.001
WHR 0.86 (0.09) 0.95 (0.09) <0.001
Hypertension (%) 190 (39 %) 128 (52 %) <0.001
Glucose (mg/dl) 91 (13) 95 (16) <0.001
Total cholesterol (mg/dl) 205 (35) 204 (39) 0.763
HDL‑cholesterol (mg/dl) 52 (14) 46 (12) <0.001
Triglycerides (mg/dl) 168 (82) 207 (89) <0.001
Dyslipidemia (%) 82 (17 %) 52 (21 %) 0.084
Diabetes (%) 40 (8 %) 29 (12 %) 0.110
Metabolic syndrome (%) 112 (23 %) 195 (79 %) <0.001
Smokers (%) 96 (20 %) 51 (21 %) 0.386
Alcohol consumption  
(g/day)
6.4 (8.6) 9.7 (13.1) <0.001
8‑OXO‑DG 3.1 (1.6) 3.4 (1.7) 0.016
MDA (μmol/mg protein) 0.59 (0.54) 0.64 (0.61) 0.289
GSH/GSSG 4.4 (2.5) 4.2 (2.6) 0.334
Vitamin A intake (µg/day) 887 (519) 772 (504) 0.009
Vitamin C intake (mg/day) 225 (137) 207 (138) 0.108
Vitamin E intake (mg/day) 10.0 (4.6) 8.7 (4.4) <0.001
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low vitamin E compared to those with diets high in vita-
min E (95.12  ±  13.14 vs. 92.4  ±  11.2  cm, p  =  0.016). 
The interaction between SNPs and vitamin E intake was 
found to significantly influence WC in a dominant [GA 
or AA] model (p  =  0.040). There were no significant 
interactions between vitamin A intake and SNPs (data 
no shown).
Molecular and functional studies in the thioredoxin 
genetic variant
We investigated possible mechanisms by which the c.-
793T  >  C promoter variation (rs2301241) affects TXN 
transcription activity. Genetic variations in the promoter 
region can influence gene expression by affecting mRNA 
transcription. Therefore, reporter constructs containing 
the rs2301241 SNP promoter in the TXN gene were pre-
pared, and their transcriptional activities were measured 
in HuH-7 human hepatocyte cells. When compared with 
the standard c.-793T allele, the transcriptional activity 
of the c.-793C variant allele was up to four times higher 
in these cells (Fig. 3). A computational search for DNA-
binding proteins using Genomatix software [34] revealed 
that heat shock factor 2 (HSF2) can bind to this reverse 
region [gtcctgacctcctGAAGtctcagtg] only when c.-793C 
allele is present in the TXN promoter.
Table 3 Selected SNP genotyping distribution of anthropometry by dominant genetic model
Values are the mean ± SEM. Differences in the mean values were assessed by ANOVA and adjusted for age, gender, education level (< high school), hypertension, 
glucose, high-density lipoprotein cholesterol, triglycerides, 8-oxodeoxyguanosine, and alcohol consumption. The values in italics are statistically significant (p < 0.05) 
and the values in italic and bold are statistically significant after Bonferroni correction (p < 0.007). P values denote differences between genotypes using a dominant 
genetic model for all of the SNPs
HGN human gene nomenclature, N number of individuals for each genotype or genotype group, HWE Hardy–Weinberg equilibrium, MAF minor allele frequency, WC 
waist circumference
HGN SNP name Genotype N WC (cm) BMI Hip (cm) WHR
CAT rs1049982 CC 264 92.2 ± 0.4 27.0 ± 0.1 104.6 ± 0.8 0.90 ± 0.01
HWE: 0.17 CT+TT 322 92.5 ± 0.3 27.4 ± 0.1 105.3 ± 0.3 0.91 ± 0.00
MAF T: 0.34 0.622 0.058 0.415 0.173
SOD3 rs2536512 AA 250 92.4 ± 0.4 27.2 ± 0.1 105.4 ± 0.8 0.91 ± 0.01
HWE: 0.23 AG+GG 335 92.3 ± 0.3 27.3 ± 0.1 105.2 ± 0.3 0.91 ± 0.00
MAF G:0.36 0.811 0.459 0.784 0.945
GPX1 rs3448 CC 340 92.1 ± 0.3 27.2 ± 0.1 106.8 ± 1.0 0.92 ± 0.01
HWE: 0.11 CT+TT 245 92.7 ± 0.4 27.3 ± 0.1 105.1 ± 0.3 0.91 ± 0.00
MAF T: 0.25 0.242 0.859 0.093 0.366
TXN rs4135168 AA 328 91.9 ± 0.3 27.3 ± 0.1 105.8 ± 0.4 0.92 ± 0.00
HWE: 0.61 AG+GG 246 92.9 ± 0.4 27.2 ± 0.1 104.5 ± 0.4 0.91 ± 0.00
MAF G:0.24 0.031 0.824 0.021 0.277
TXN rs2301241 TT 172 93.4 ± 0.4 27.1 ± 0.2 106.3 ± 0.5 0.91 ± 0.01
HWE: 0.24 TC+CC 415 91.9 ± 0.3 27.3 ± 0.1 104.7 ± 0.3 0.91 ± 0.00
MAF C:0.47 0.004 0.322 0.01 0.847
COMT rs740603 GG 225 93.3 ± 0.4 27.0 ± 0.2 105.7 ± 0.4 0.92 ± 0.00
HWE: 0.75 GA+AA 355 91.6 ± 0.3 27.4 ± 0.1 104.9 ± 0.4 0.91 ± 0.00
MAF A:0.38 0.001 0.088 0.159 0.139
Fig. 1 Summary of multi‑factor dimensionality (MDR). The results of 
MDR for two‑locus genotype combinations associated with abdomi‑
nal obesity, as estimated by waist circumference. The distribution 
of abdominal obesity cases (left bars) and non‑abdominal obesity 
controls (right bars) for each genotype combination are shown. The 
cells shaded in dark grey are considered to be “high risk” and the cells 
shaded in light grey are considered “low risk”
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The plasma TXN level was measured in a subset of 
88 individuals selected according to their rs2301241 
genotypes and was found to be directly related to WC 
(r = 0.596, p < 0.001). Although no differences in plasma 
TXN levels between rs2301241 polymorphism genotypes 
were found, there was a trend toward significance for the 
interaction between rs2301241, plasma TXN levels, and 
vitamin E intake (p = 0.114), with higher levels of plasma 
TXN present in C-allele individuals who consumed diets 
low in vitamin E (Fig. 4).
Discussion
In our study population the rs2301241 (TXN gene) and 
rs740603 (COMT gene) polymorphisms were associated 
with WC in low vitamin E intake individuals. Moreover, 
a significant gene–gene interaction was found between 
these two SNPs, WC, and AO, thus providing the first 
evidence that the TXN and COMT gene variations modu-
late the effect of dietary vitamin E on WC. In this popula-
tion, AO was associated with an increase in 8-OXO-DG 
and with a decrease in vitamin A and vitamin E intake. 
These data concur with recent studies suggesting that sys-
temic OS correlates with obesity, BMI, and fat mass [35]. 
It is known that OS can increase adipocyte hypertrophy, 
cellular stress, cytokine and adipokine secretion, and 
the degradation of many proteins involved in metabolic 
regulation [11]. In turn, low vitamin A and E intake were 
associated with AO, and there was also a trend toward a 
significant association with low vitamin C intake, as previ-
ously reported by other authors [14]. In fact, recent evi-
dence suggests that some micronutrient deficiencies are 
related to obesity and fat deposition: specifically, vitamin 
A is a known regulator of adipose tissue growth [36].
AO is believed to be a greater risk factor for cardio-
vascular health than for obesity. Giving weight to this 
idea, our finding that there was a significant association 
between the studied polymorphisms and WC but not 
BMI supports the notion that weight and fat distribution 
are regulated by different genes. In this study we only 
found an association with WC in two of the seven SNPs 
we studied: there was no association with the CAT, SOD, 
or GPX1 SNPs and anthropometry suggests the ROS/
OS pathways may not be directly related to WC via these 
genes. Although these enzymes have been linked to some 
types of obesity or metabolic syndrome [37] we did not 
find any significant associations between these SNPs and 
different anthropometric parameters.
However, the TXN and COMT genes were related to 
OS mechanisms that have been associated with WC. 
Fig. 2 Analysis of the interaction between rs2301241 (a), rs740603 (b), and vitamin E intake on waist circumference. Data are the mean (±SEM). P 
values were assessed by one‑way analysis of variance (ANOVA) and adjusted by age, gender, education level (<high school), hypertension, glucose, 
high‑density lipoprotein cholesterol, triglycerides, 8‑oxodeoxyguanosine, and alcohol consumption
Fig. 3 Analysis of transcriptional activity in the −952 to +17 region 
of human TXN promoter. HuH‑7 cells were transiently transfected 
with 1 mg of luciferase reporter constructs and 50 ng of a promoter 
less renilla plasmid. Luciferase activity was normalized against the 
values of the renilla internal control. The data represent mean ± SEM 
(n = 3) and are expressed as fold‑induction with respect to the empty 
vector (pGL3basic). *p < 0.005 with the TXN c.‑793T and TXN c.‑793C 
constructs
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The protein encoded by TXN acts as a homodimer and 
is involved in many redox reactions. For example, a novel 
interaction between upregulated TXN-TXNRD1-system 
mediated OS defense mechanisms and downregulated 
angiogenesis pathways was recently described as an 
adaptive response in obese subjects [38]. In addition, this 
antioxidant protein has been related to glucose metabo-
lism in adipocytes and in other tissues [39–41]. Inter-
estingly, we showed that vitamin E can protect against 
increases in WC in carriers of the rs2301241 (TXN) T 
allele and that this group tends to maintain plasma TXN 
levels similar to C allele carriers. Similarly, England et al. 
(2012) reported that the effect of α-tocopherol supple-
mentation on the production of inflammatory cytokines 
appears to be dependent on SNP genotypes in genes 
involved in inflammation or responses to OS in healthy 
volunteers [42]. These genotype-specific differences may 
help explain some of the discordant results in studies that 
used vitamin E supplementation.
The protein encoded by COMT catalyzes the transfer 
of a methyl group from S-adenosyl methionine to cat-
echolamines, including the neurotransmitters dopamine, 
epinephrine, and norepinephrine [43]. In addition, the 
influence of catecholamines and sex steroids on food 
intake/satiety [44] and metabolism [45] is well known. A 
recent study has found that carriers of the COMT poly-
morphism valine allele (V158M) tend to have a higher 
BMI than those with the Met158 allele [46]. In our popu-
lation, we found a protector polymorphism (rs740603) 
which was related to WC and vitamin E intake. This vari-
ation is a tag-SNP located in an intronic region of COMT. 
Furthermore Ittiwut et al. (2011) reported that this poly-
morphism has potentially-functional variants which are 
related to a psychiatric phenotype [47]. Concerning the 
interaction between vitamin E and COMT, our findings 
show that the GG homozygote subjects who consumed 
a low vitamin E diet had significantly higher WCs than 
those carrying the A allele. Thus, these results are con-
sistent with the well-known protective effects of vitamin 
E against COMT activity [48]. Moreover, we performed 
epistatic analysis on the two genes which were the most 
significantly related to WC and susceptibility to AO 
(TXN and COMT) using the MDR method, showing 
that the combination of the two variants (rs2301241 and 
rs740603) is associated with higher WC and AO than 
the individual variants. However, how this combination 
affects AO or fat storage-related mechanisms remains to 
be tested.
The TXN system is upregulated in high-stress oxidative 
conditions such as during hypertension episodes (while 
the GSH system is downregulated [49]), however, this 
activation still seems insufficient for maintaining a nor-
mal redox status in these patients. We hypothesize that 
high WC, associated with increased OS, increases TXN 
expression and plasma levels of this protein, and there-
fore T-allele carriers, who have intrinsically lower TXN 
activity, have a higher risk of AO. Moreover, the TXN 
rs2301241 SNP, which is associated with WC, is located 
between the promoter region and the first intron of 
this gene which means that it could be involved in gene 
expression regulation since binding of several transcrip-
tion factors is extremely sensitive to polymorphisms in 
regulatory regions. We used Genomatix software [34] to 
assess the potential functionality of the TXN rs2301241 
(c.-793T  >  C) by testing its response to consensus ele-
ments in the entire TXN promoter. The c.-793C allele 
site matched a core binding-consensus motif for heat 
shock transcription factor 2 (HSF2) which induces TXN 
expression at the mRNA and protein levels [50]. The 
fact that HSF2 can only bind to this reverse region [gtc-
ctgacctcctGAAGtctcagtg] when the c.-793C allele is pre-
sent indicates the functionality of this polymorphism, 
and importantly, the differences in TXN transcription 
we describe between groups may be explained by the 
reduced ability that TT carriers have to produce normal 
levels of TXN mRNA. This correlates with the reduced 
levels of TXN we found in plasma in T allele carriers, 
although further studies would be required to further test 
this hypothesis.
This study should be read and understood within its 
strengths and limitations. Regarding the former, the age 
and sex matched cohort we studied was selected from a 
Fig. 4 Analysis of the interaction between rs2301241 and vitamin 
E intake on plasma TXN levels. Data shown are the mean (±SEM). 
p (p value) was assessed by ANOVA and adjusted by age, gender, 
education level (<high school), hypertension, glucose, high‑density 
lipoprotein cholesterol, triglycerides, 8‑oxodeoxyguanosine, and 
alcohol consumption
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Spanish region with a very low immigration rate which 
minimizes error due to population stratification. and 
the statistics-matching allows to estimate the effect of 
the outcome without reduced bias due to confounding 
factors [51], functional study and bioinformatic analy-
sis of the possible effect of TXN polymorphism was 
evaluated. Moreover it is noteworthy that the associa-
tions with SNPs were significant and correlated with 
AO after the adjustment by known confounding vari-
ables, and also attached to AO in this study, such as 
demographic characteristics (including education 
level), alcohol consumption, biochemical parameters, 
and presence of other cardiovascular risk factors. In 
addition, it is important to note that Vitamin E is pro-
tective for non-alcoholic fatty liver disease [52]; there-
fore our data also suggest that subjects with AO should 
increase their vitamin E intake levels to help with this 
problem, although this is more important for those with 
the rs2301241 (TXN) TT or the rs740603 (COMT) GG 
genotype. Taking this idea further, by genotyping AO 
subjects it may be possible to identify a subpopulation 
of higher-risk allele carriers for which vitamin E supple-
mentation might be beneficial and perhaps protective. 
However before reaching this conclusion more defini-
tive tests in other groups and populations with different 
levels of vitamin E intake, as well as studies in different 
animal models of AO or obesity, will be required; finally, 
this hypothesis should be tested in prospective studies 
in order to confirm any effects of increased vitamin E 
intake.
The main limitations of this study were the absence 
of a second population to test the replicability of our 
results, the low reproducibility of the 24-h dietary recall 
for vitamin intake (despite using validated surveys), and 
the lack of plasma vitamin level data which we could use 
to validate reported dietary vitamin intake. Concerning 
the 24-h dietary recalls, recent articles have specifically 
shown that the reproducibility of recall by either gender 
is moderate for vitamin E intake [53]. Moreover, although 
intake levels and final blood levels are related there are 
several factors that modify blood levels and there are 
some major inter-individual variations which can effect 
plasma levels despite similar initial vitamin intake. Nev-
ertheless, plasma vitamin E concentrations tend to vary 
little over a wide range of dietary intakes. Kinetic stud-
ies with tocopherol suggest that its equilibration into new 
erythrocytes, liver, and spleen cells is rapid but that turn-
over in other tissues such as heart, muscle, and adipose 
tissue is much slower [54]. Another important aspect 
to consider is the assumption that WC is an indication 
of abdominal adiposity, although accurate abdominal fat 
content measurement requires the use of expensive tech-
niques (dual energy X-ray absorptiometry, or whole-body 
air displacement plethysmography). Therefore the use 
of WC as a surrogate marker of abdominal fat mass has 
become an economic, easy, and robust method of obtain-
ing a clinical indication of visceral adiposity. Moreo-
ver, it is well established that WC is associated with an 
increased risk of cardiometabolic syndrome [55] and that 
it correlates with abdominal fat mass (both subcutaneous 
and intra-abdominal) [56].
Conclusions
This study provides the first evidence that genetic vari-
ation in OS-related genes can modulate WC in relation 
to dietary vitamin E intake. Our results indicate the pres-
ence of significant associations, in a Spanish population, 
between two polymorphisms (in the TXN and COMT 
genes) and WC, which is influenced by vitamin E intake. 
In addition, we demonstrate the effect of the rs2301241 
polymorphism on TXN expression levels, and thus call 
for further studies to identify the mechanisms linking 
this gene to WC.
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